Embryos donated to science blow the whistle on CRISPR
By Alison Motluk,
HeyReprotech Newsletter
| 06. 23. 2020
The controversial gene-editing technique mis-snips again. And thanks to embryos donated to science, we know about it.
Many people, finding themselves at the end of their reproductive journey, decide to donate their extra embryos "to science." We don't hear all that much about what becomes of these embryos — what scientific advancements they enabled, what policies they influenced, what practices they helped to curtail.
Here is one such story.
Twenty-five embryos were volunteered into a study using CRISPR, a controversial gene-editing technique. (For a bit of background on the science and politics of CRISPR, see this round-up.) All the couples who donated their embryos gave informed consent. They were told about the research project, were given an opportunity to receive counselling about their decision, and agreed that any results from their contribution could be published in scientific journals. No money changed hands for the embryos.
Some of the findings generated by studying these embryos ended up in one of the world's most prestigious scientific journals, Nature, in this study about the role of a particular gene (POU5F1) in early embryological development.
But those embryos went on to play a role in a second...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...